MedTrace Logo

Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants

NCT06820307 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-05-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of SUZ on the pharmacokinetics of oral contraceptives.

Conditions

Interventions

DRUG

Suzetrigine

Tablets for Oral Administration.

DRUG

DRSP/EE

Combination Tablets for Oral Administration.

DRUG

NGM/EE

Combination Tablets for Oral Administration.

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-25
Primary Completion
2025-04-29
Completion
2025-04-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06820307 on ClinicalTrials.gov